CDKN1B and cancer: While the cell cycle inhibitory role of p27 has been extensively described in different types of human cancer, other studies question the beneficial role of p27 and show a reduction in nuclear p27 and a gain in cytoplasmic p27 after oncogenic stimuli, thereby increasing tumor progression and malignancy [20,28,29].